Human endothelial gelatinases and angiogenesis

International Journal of Biochemistry and Cell Biology

Volumn 33, Issue 10, 2001, Pages 960-970

  Nguyen, Minh ^a   Arkell, Jacky ^a   Jackson, Christopher J ^a  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

Gelatinases; Human endothelial cells; Membrane type matrix metalloproteinase; Thrombin; Type I collagen matrix

Indexed keywords

GELATINASE; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; PROTEIN C; THROMBIN;

ANGIOGENESIS; BASEMENT MEMBRANE; CELL INVASION; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME REGULATION; ENZYME RELEASE; HUMAN; HUMAN CELL; INTERSTITIUM; PROTEIN FAMILY; REVIEW;

CELL MEMBRANE; COLLAGEN; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; ENZYME PRECURSORS; EXTRACELLULAR MATRIX; GELATINASES; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; NEOVASCULARIZATION, PHYSIOLOGIC; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 0034905196     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(01)00007-3     Document Type: Review

References (71)

1. Angiogenesis in cancer, vascular, rheumatoid and other disease
2. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
3. Tumour angiogenesis: Therapeutic implications
4. Basement membrane synthesis and degradation
5. Role of matrix metalloproteinases in human periodontal diseases
6. Inhibition of ovulation in the perfused rat ovary by the synthetic collagenase inhibitor SC 44463
7. Mechanism of control of trophoblast invasion in situ
8. Expression of interstitial collagenase during skeletal development of the mouse is restricted to osteoblast-like cells and hypertrophic chondrocytes
9. Two distinct phases of apoptosis in mammary gland involution: Proteinase-independent and -dependent pathways
10. Matrix metalloproteinases in angiogenesis: A moving target for therapeutic intervention
11. Metalloproteinase inhibitors and the prevention of connective tissue breakdown
12. Matrix metalloproteinases degrade myelin basic protein
13. Matrix metalloproteinases and metastasis
14. Identification and characterization of human endometase (Matrix Metalloproteinase-26) from endometrial tumor
15. Matrix metalloproteinases and their inhibitors in connective tissue remodelling
16. The matrix-degrading metalloproteinases
17. Matrix metalloproteinase expressed on the surface of invasive tumour cells
18. Expression of three membrane-type matrix metalloproteinase (MT-MMPs) in rat vascular smooth muscle cells and characterization of MT3-MMP with and without transmembrane domain
19. Identification of the second membrane-type matrix metalloproteinase (MT2-MMP) gene from a human placenta cDNA library - MT-MMP form a unique membrane-type subclass in the MMP family
20. A helping hand for collagenases - The haemopexin-like domain
21. The C-terminal domain of 72 kDa gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases
22. Cell surface-mediated activation of progelatinase A: Demonstration of the involvement of the C-terminal domain of progelatinase A in cell surface binding and activation of progelatinase A by primary fibroblasts
23. Tumor-promoting phorbol esters induce angiogenesis in vitro
24. Identification of an inhibitor of neovascularization from cartilage
25. Interstitial collagenase is required for angiogenesis in vitro
26. Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro
27. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3
28. Three-dimensional type I collagen lattices induce coordinate expression of matrix metalloproteinases MT1-MMP and MMP-2 in microvascular endothelial cells
29. Gelatinases A and B
30. Matrix metalloproteinase-2 is an interstitial collagenase
31. Reciprocated matrix metalloproteinase activation: A process performed by interstitial collagenase and progelatinase A
32. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice
33. Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity
34. 3
35. Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model
36. Tumor targeting with a selective gelatinase inhibitor
37. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes
38. SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages
39. Complete structure of the human gene for 92-kD type IV collagenase
40. Human dermal microvascular endothelial cells produce matrix metalloproteinases in response to angiogenic factors and migration
41. Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells - Effects of TNF-α, interleukin-1 and phorbol ester
42. Lymphocytes induce endothelial cell matrix metalloproteinase expression by a CD40L-dependent mechanism - Implications for tubule formation
43. Active and tissue inhibitor of matrix metalloproteinase-free gelatinase B accumulates within human microvascular endothelial vesicles
44. Localization of matrix metalloproteinase-9 to the cell surface provides a mechanism for CD44-mediated tumour invasion
45. Positive and negative transcriptional elements of the human type IV collagenase gene
46. r 72 000 type IV collagenase gene and enhanced expression in a highly metastatic cell line
47. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the pro-peptide of pro-gelatinase A and initiates autoproteolytic activation
48. The TIMP-2 membrane type 1 metalloproteinase receptor regulates the concentration and efficient activation of progelatinase A - A kinetic study
49. Matrix metalloproteinase-2 activation modulates glioma cell migration
50. Plasma membrane-dependent activation of gelatinase A in human vascular endothelial cells
51. Activation of human umbilical vein endothelial cell progelatinase A by phorbol myristate acetate - A protein kinase C-dependent mechanism involving a membrane-type matrix metalloproteinase
52. Membrane-type matrix metalloproteinases in human dermal microvascular endothelial cells: Expression and morphogenetic correlation
53. Three-dimensional collagen matrices induce delayed but sustained activation of gelatinase A in human endothelial cells via MT1-MMP
54. Thrombin induces the activation of progelatinase A in vascular endothelial cells-physiologic regulation of angiogenesis
55. Thrombin rapidly and efficiently activates gelatinase A in human microvascular endothelial cells via a mechanism independent of active MT1-MMP
56. Inflammation - The protein C pathway
57. Activation mechanism of anticoagulant protein C in large blood vessels involving the endothelial cell protein C receptor
58. Activated protein C directly activates human endothelial gelatinase A
59. 2 exposure
60. Hepatocyte growth factor enhances MMP activity in human endothelial cells
61. Lipopolysaccharide activates matrix metalloproteinase-2 in endothelial cells through an NF-kB-dependent pathway
62. Inflammatory cytokines and oxidized low density lipoproteins increase endothelial cell expression of membrane type 1-matrix metalloproteinase
63. Heterogenenous regional expression patterns of matrix metalloproteinases in human malignant gliomas
64. Thrombin receptor overexpression in malignant and physiological invasion process
65. Thrombin increases the metastatic potential of tumor cells
66. Thrombin in inflammation and healing - Relevance to rheumatoid arthritis
67. Regulation of thrombin generation and functions
68. Plasma membrane-bound tissue inhibitor of metalloproteinases (TIMP-2) specifically inhibits matrix metalloproteinase-2 (gelatinase A) activated on the cell surface
69. Kinetic analysis of the binding of human matrix metalloproteinase-2 and -9 to tissue inhibitor of metalloproteinase TIMP-1 and TIMP-2
70. Regulation of the autoactivation of human 72-kDa progelatinase by tissue inhibitor of metalloprotinase-2
71. Angiogenesis - A paradigm for balanced extracellular proteolysis during cell migration and morphogenesis